Cargando…

Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary

BACKGROUND: The excess risks of mortality and cardiovascular morbidity among patients with type 2 diabetes mellitus (T2DM) is well known. In this nationwide study, we assessed risks of mortality and cardiovascular events comparing patients with T2DM and matched controls. METHODS: We identified patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiss, Zoltán, Rokszin, György, Abonyi-Tóth, Zsolt, Jermendy, György, Kempler, Péter, Aradi, Dániel, Wittmann, István
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062985/ https://www.ncbi.nlm.nih.gov/pubmed/30053870 http://dx.doi.org/10.1186/s12933-018-0751-7

Ejemplares similares

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis
por: Jermendy, György, et al.
Publicado: (2022)

Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013
por: Kiss, Zoltan, et al.
Publicado: (2019)

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study
por: Barkai, László, et al.
Publicado: (2019)

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study
por: Jermendy, György, et al.
Publicado: (2018)

Persistence with statin therapy in Hungary
por: Kiss, Zoltan, et al.
Publicado: (2013)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study
por: Sütő, Gábor, et al.
Publicado: (2021)

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study
por: Rokszin, György, et al.
Publicado: (2021)

Lung cancer drug therapy in Hungary – 3-year experience
por: Moldvay, Judit, et al.
Publicado: (2015)

Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary
por: Kiss, Zoltan, et al.
Publicado: (2021)

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
por: Bogos, Krisztina, et al.
Publicado: (2019)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
por: Tamási, Lilla, et al.
Publicado: (2021)

Assessment of cardiometabolic risk among shift workers in Hungary
por: Jermendy, György, et al.
Publicado: (2012)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
por: Vokó, Zoltán, et al.
Publicado: (2022)

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study
por: Liszkay, Gabriella, et al.
Publicado: (2021)

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
por: Vokó, Zoltán, et al.
Publicado: (2022)

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020
por: Kiss, Zoltán, et al.
Publicado: (2023)

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)
por: Kiss, Zolta´n, et al.
Publicado: (2022)

Incremental cost of premature birth – a public health care payer perspective from Hungary
por: Kovács, Gábor, et al.
Publicado: (2023)

An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the PLUS Program
por: Mark, Laszlo, et al.
Publicado: (2011)

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
por: Bogos, Krisztina, et al.
Publicado: (2021)

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
por: Kiss, Zoltán, et al.
Publicado: (2022)

Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire
por: Winkler, Gábor, et al.
Publicado: (2013)

Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008
por: Mark, Laszlo, et al.
Publicado: (2010)

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary
por: Jermendy, György, et al.
Publicado: (2008)

Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance
por: Putz, Zsuzsanna, et al.
Publicado: (2009)

Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry
por: Kenessey, István, et al.
Publicado: (2022)

May Measurement Month 2017: an analysis of blood pressure screening in Hungary—Europe
por: Nemcsik, János, et al.
Publicado: (2019)

Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study
por: Jermendy, György, et al.
Publicado: (2011)

Hungary at CERN / Magyarország és a CERN
por: György Vesztergombi
Publicado: (2008)

Health behaviour and cardiovascular risk in women living in a disadvantaged region in Hungary
por: Rucska, A, et al.
Publicado: (2023)

May Measurement Month 2019: an analysis of blood pressure screening results from Hungary
por: Nemcsik, János, et al.
Publicado: (2021)

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
por: Bogos, Krisztina, et al.
Publicado: (2021)

Exploring park visitation trends during the Covid-19 pandemic in Hungary by using mobile device location data
por: Csomós, György, et al.
Publicado: (2023)

Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - results from a nationwide clinical audit
por: Kiss, István, et al.
Publicado: (2013)

Europhile Public vs Eurosceptic Governing Elite in Hungary?
por: Göncz, Borbála, et al.
Publicado: (2021)

Vascular memory: can we broaden the concept of the metabolic memory?
por: Jermendy, György
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6apvich4b5inos6jnf8jh05dds